BEHAVIORAL-RESEARCH ON AIDS - PROTEASE INHIBITORS AND THE NEW MILLENNIUM - COMMENT ON KELLY, OTTO-SALAJ, SIKKEMA, PINKERTON, AND BLOOM (1998)

The use of combination antiretroviral therapy in conjunction with the clinical use of viral load measurements have contributed to the ''resu rrection'' of thousands of individuals who were expected to be on a do wnward spiral with symptomatic HIV/AIDS. In this context, those living with HIV face a host of new challenges, such as adhering to complicat ed medication regimens, maintaining low levels of HN risk behaviors, r eassessing future goals, and considering return to work, These issues, and others, present behavioral health practitioners and researchers w ith an exciting agenda for research and intervention. In pursuing this agenda, it is vital that innovations in health psychology maintain pa ce and integrate seamlessly with rapidly developing medical advances i n the field. In so doing, health psychology will maintain its critical role in combating the HIV epidemic in this new era of treatment.